Weiser Michael's Form 4 filing
Iovance Biotherapeutics, Inc. (IOVA) · filed Jun 2, 2022
- Accession no.
- 0001104659-22-067761
- Filed
- Jun 2, 2022
- Trade date
- May 31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $68.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weiser MichaelCIK 0001221449 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 31, 2022 | Common Stock | PPurchaseAcquired | +2,187 | $6.79 | +$14,849.73 | 104,819 | Direct | |
| May 31, 2022 | Common Stock | PPurchaseAcquired | +7,813 | $6.80 | +$53,128.4 | 112,632 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.